Dier Mardi (Officer) plans to sell 1,336 MDGL shares, about $586,958
- Form
- 144
- Filed
- Importance
- Routine
- Accession
- 0001950047-26-002326
- Approximate sale date: Mar 6, 2026
- Broker: Morgan Stanley Smith Barney LLC Executive Financial Services
- Shares acquired by: Restricted Stock Units
- 10b5-1 plan adopted: Sep 2, 2025
All of Dier Mardi's insider filings, holdings and planned sales
Form 4s that likely executed this notice (SEC Tracker's match by person, company, dates and shares):
- Sold 40 shares at $425.08 on Mar 6, 2026 · Form 4
- Sold 420 shares at $426.86 on Mar 6, 2026 · Form 4
- Sold 80 shares at $427.85 on Mar 6, 2026 · Form 4
- Sold 160 shares at $429 on Mar 6, 2026 · Form 4
- Sold 40 shares at $429.58 on Mar 6, 2026 · Form 4
- Sold 120 shares at $430.9 on Mar 6, 2026 · Form 4
- Sold 116 shares at $432.56 on Mar 6, 2026 · Form 4
- Sold 160 shares at $434.2 on Mar 6, 2026 · Form 4
- Sold 80 shares at $435.32 on Mar 6, 2026 · Form 4
- Sold 80 shares at $436.69 on Mar 6, 2026 · Form 4
- Sold 40 shares at $437.65 on Mar 6, 2026 · Form 4
Written from the Form 144 on EDGAR. AI can make mistakes. Check the filing.
Similar companies
Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.
- Ionis Pharmaceuticals IONS public float $5.3B, Jun 30, 2025
- Repligen RGEN public float $6.0B, Jun 30, 2025
- Corcept Therapeutics CORT public float $6.1B, Jun 30, 2025
- Jazz Pharmaceuticals JAZZ public float $6.3B, Jun 30, 2025
- Biomarin Pharmaceutical BMRN public float $6.7B, Jun 30, 2025